位置:首页 > 蛋白库 > QCRB_MYCTU
QCRB_MYCTU
ID   QCRB_MYCTU              Reviewed;         549 AA.
AC   P9WP37; L0TAG7; P63885; Q10388;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 1.
DT   03-AUG-2022, entry version 42.
DE   RecName: Full=Cytochrome bc1 complex cytochrome b subunit;
DE            EC=7.1.1.8 {ECO:0000305};
DE   AltName: Full=Cytochrome bc1 reductase complex subunit QcrB;
DE   AltName: Full=Ubiquinol--cytochrome c reductase cytochrome b subunit;
GN   Name=qcrB; OrderedLocusNames=Rv2196; ORFNames=MTCY190.07;
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [2]
RP   IDENTIFICATION AS A DRUG TARGET [LARGE SCALE ANALYSIS].
RX   PubMed=19099550; DOI=10.1186/1752-0509-2-109;
RA   Raman K., Yeturu K., Chandra N.;
RT   "targetTB: a target identification pipeline for Mycobacterium tuberculosis
RT   through an interactome, reactome and genome-scale structural analysis.";
RL   BMC Syst. Biol. 2:109-109(2008).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [4]
RP   FUNCTION, ACTIVITY REGULATION, AND MUTAGENESIS OF THR-313.
RC   STRAIN=H37Rv;
RX   PubMed=23913123; DOI=10.1038/nm.3262;
RA   Pethe K., Bifani P., Jang J., Kang S., Park S., Ahn S., Jiricek J.,
RA   Jung J., Jeon H.K., Cechetto J., Christophe T., Lee H., Kempf M.,
RA   Jackson M., Lenaerts A.J., Pham H., Jones V., Seo M.J., Kim Y.M., Seo M.,
RA   Seo J.J., Park D., Ko Y., Choi I., Kim R., Kim S.Y., Lim S., Yim S.A.,
RA   Nam J., Kang H., Kwon H., Oh C.T., Cho Y., Jang Y., Kim J., Chua A.,
RA   Tan B.H., Nanjundappa M.B., Rao S.P., Barnes W.S., Wintjens R.,
RA   Walker J.R., Alonso S., Lee S., Kim J., Oh S., Oh T., Nehrbass U.,
RA   Han S.J., No Z., Lee J., Brodin P., Cho S.N., Nam K., Kim J.;
RT   "Discovery of Q203, a potent clinical candidate for the treatment of
RT   tuberculosis.";
RL   Nat. Med. 19:1157-1160(2013).
RN   [5]
RP   FUNCTION, ACTIVITY REGULATION, MUTAGENESIS OF LEU-176 AND THR-313, AND
RP   3D-STRUCTURE MODELING.
RC   STRAIN=H37Rv;
RX   PubMed=26158909; DOI=10.1038/ncomms8659;
RA   Rybniker J., Vocat A., Sala C., Busso P., Pojer F., Benjak A., Cole S.T.;
RT   "Lansoprazole is an antituberculous prodrug targeting cytochrome bc1.";
RL   Nat. Commun. 6:7659-7659(2015).
CC   -!- FUNCTION: Cytochrome b subunit of the cytochrome bc1 complex, an
CC       essential component of the respiratory electron transport chain
CC       required for ATP synthesis. The bc1 complex catalyzes the oxidation of
CC       ubiquinol and the reduction of cytochrome c in the respiratory chain.
CC       The bc1 complex operates through a Q-cycle mechanism that couples
CC       electron transfer to generation of the proton gradient that drives ATP
CC       synthesis. The cytochrome b subunit contains two ubiquinol reactive
CC       sites: the oxidation (QP) site and the reduction (QN) site.
CC       {ECO:0000305, ECO:0000305|PubMed:23913123,
CC       ECO:0000305|PubMed:26158909}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinol + 2 Fe(III)-[cytochrome c](out) = a quinone + 2
CC         Fe(II)-[cytochrome c](out) + 2 H(+)(out); Xref=Rhea:RHEA:11484,
CC         Rhea:RHEA-COMP:10350, Rhea:RHEA-COMP:14399, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:24646, ChEBI:CHEBI:29033, ChEBI:CHEBI:29034,
CC         ChEBI:CHEBI:132124; EC=7.1.1.8; Evidence={ECO:0000305};
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000250|UniProtKB:P00163};
CC       Note=Binds 2 heme groups non-covalently per subunit.
CC       {ECO:0000250|UniProtKB:P00163};
CC   -!- ACTIVITY REGULATION: Inhibited by the anti-tuberculous drug Q203, an
CC       optimized imidazopyridine amide (IPA) compound. Q203 triggers a rapid
CC       ATP depletion in M.tuberculosis grown under an aerobic or anaerobic
CC       atmosphere (PubMed:23913123). Also inhibited by LPZS (lansoprazole
CC       sulfide), a metabolite of LPZ (lansoprazole) generated by intracellular
CC       sulfoxide reduction into the host cytoplasm; LPZS is a potent anti-
CC       mycobacterial agent that inhibits growth of intracellular
CC       M.tuberculosis with good activity against drug-resistant isolates. The
CC       inhibition of QcrB by LPZS leads to disruption of the mycobacterial
CC       respiratory chain and massive and rapid ATP depletion
CC       (PubMed:26158909). Both compounds target the same active site in QcrB
CC       (the ubiquinol oxidation QP site), but they have distinct drug-binding
CC       mechanisms (PubMed:26158909). {ECO:0000269|PubMed:23913123,
CC       ECO:0000269|PubMed:26158909}.
CC   -!- SUBUNIT: The cytochrome bc1 complex is composed of a cytochrome b
CC       (QcrB), the Rieske iron-sulfur protein (QcrA) and a diheme cytochrome c
CC       (QcrC) subunit. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000255}; Multi-pass membrane
CC       protein {ECO:0000255}.
CC   -!- MISCELLANEOUS: Was identified as a high-confidence drug target.
CC       {ECO:0000303|PubMed:19099550}.
CC   -!- SIMILARITY: Belongs to the cytochrome b family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00968}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL123456; CCP44973.1; -; Genomic_DNA.
DR   PIR; E70784; E70784.
DR   RefSeq; NP_216712.1; NC_000962.3.
DR   RefSeq; WP_003899212.1; NZ_NVQJ01000008.1.
DR   PDB; 7E1V; EM; 2.68 A; B/N=1-549.
DR   PDB; 7E1W; EM; 2.67 A; B/N=1-549.
DR   PDB; 7E1X; EM; 2.93 A; B/N=1-549.
DR   PDBsum; 7E1V; -.
DR   PDBsum; 7E1W; -.
DR   PDBsum; 7E1X; -.
DR   AlphaFoldDB; P9WP37; -.
DR   SMR; P9WP37; -.
DR   STRING; 83332.Rv2196; -.
DR   ChEMBL; CHEMBL4295794; -.
DR   PaxDb; P9WP37; -.
DR   DNASU; 887400; -.
DR   GeneID; 45426172; -.
DR   GeneID; 887400; -.
DR   KEGG; mtu:Rv2196; -.
DR   TubercuList; Rv2196; -.
DR   eggNOG; COG1290; Bacteria.
DR   OMA; WNYGPYD; -.
DR   PhylomeDB; P9WP37; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0005887; C:integral component of plasma membrane; HDA:MTBBASE.
DR   GO; GO:0005886; C:plasma membrane; HDA:MTBBASE.
DR   GO; GO:0070469; C:respirasome; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008121; F:ubiquinol-cytochrome-c reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0022904; P:respiratory electron transport chain; IEA:InterPro.
DR   Gene3D; 1.20.810.10; -; 1.
DR   InterPro; IPR005797; Cyt_b/b6_N.
DR   InterPro; IPR027387; Cytb/b6-like_sf.
DR   InterPro; IPR016174; Di-haem_cyt_TM.
DR   Pfam; PF13631; Cytochrom_B_N_2; 1.
DR   SUPFAM; SSF81342; SSF81342; 1.
DR   PROSITE; PS51002; CYTB_NTER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Electron transport; Heme; Iron; Membrane;
KW   Metal-binding; Reference proteome; Respiratory chain; Translocase;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..549
FT                   /note="Cytochrome bc1 complex cytochrome b subunit"
FT                   /id="PRO_0000061927"
FT   TRANSMEM        45..65
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00968"
FT   TRANSMEM        118..138
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00968"
FT   TRANSMEM        146..166
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00968"
FT   TRANSMEM        189..209
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00968"
FT   TRANSMEM        217..237
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00968"
FT   TRANSMEM        266..286
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00968"
FT   TRANSMEM        335..355
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00968"
FT   TRANSMEM        381..401
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00968"
FT   TRANSMEM        418..438
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00968"
FT   BINDING         114
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_label="1"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00968"
FT   BINDING         128
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_label="2"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00968"
FT   BINDING         216
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_label="1"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00968"
FT   BINDING         231
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_label="2"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00968"
FT   MUTAGEN         176
FT                   /note="L->P: Confers resistance to LPZS. Remains
FT                   susceptible to IPA."
FT                   /evidence="ECO:0000269|PubMed:26158909"
FT   MUTAGEN         313
FT                   /note="T->A: Confers resistance to Q203 and IPA. Remains
FT                   susceptible to LPZS."
FT                   /evidence="ECO:0000269|PubMed:23913123,
FT                   ECO:0000269|PubMed:26158909"
FT   HELIX           15..25
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   HELIX           30..35
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   HELIX           43..46
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   HELIX           47..65
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   TURN            66..68
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   STRAND          75..77
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   HELIX           83..85
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   STRAND          89..91
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   HELIX           92..103
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   HELIX           107..135
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   TURN            136..138
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   HELIX           140..142
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   HELIX           143..164
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   HELIX           170..184
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   STRAND          187..190
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   HELIX           192..199
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   STRAND          200..204
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   HELIX           208..217
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   HELIX           219..237
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   STRAND          254..257
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   HELIX           258..283
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   TURN            289..291
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   TURN            308..310
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   HELIX           311..318
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   STRAND          325..327
FT                   /evidence="ECO:0007829|PDB:7E1V"
FT   STRAND          330..332
FT                   /evidence="ECO:0007829|PDB:7E1V"
FT   HELIX           335..348
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   TURN            349..351
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   HELIX           352..360
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   TURN            372..374
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   HELIX           376..394
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   HELIX           398..404
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   HELIX           409..447
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   STRAND          454..456
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   TURN            458..461
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   TURN            493..495
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   STRAND          496..499
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   STRAND          505..509
FT                   /evidence="ECO:0007829|PDB:7E1W"
FT   HELIX           513..536
FT                   /evidence="ECO:0007829|PDB:7E1W"
SQ   SEQUENCE   549 AA;  61014 MW;  0E75E0BCAA46B3A7 CRC64;
     MSPKLSPPNI GEVLARQAED IDTRYHPSAA LRRQLNKVFP THWSFLLGEI ALYSFVVLLI
     TGVYLTLFFD PSMVDVTYNG VYQPLRGVEM SRAYQSALDI SFEVRGGLFV RQIHHWAALM
     FAAAIMVHLA RIFFTGAFRR PRETNWVIGS LLLILAMFEG YFGYSLPDDL LSGLGLRAAL
     SSITLGMPVI GTWLHWALFG GDFPGTILIP RLYALHILLL PGIILALIGL HLALVWFQKH
     TQFPGPGRTE HNVVGVRVMP VFAFKSGAFF AAIVGVLGLM GGLLQINPIW NLGPYKPSQV
     SAGSQPDFYM MWTEGLARIW PPWEFYFWHH TIPAPVWVAV IMGLVFVLLP AYPFLEKRFT
     GDYAHHNLLQ RPRDVPVRTA IGAMAIAFYM VLTLAAMNDI IALKFHISLN ATTWIGRIGM
     VILPPFVYFI TYRWCIGLQR SDRSVLEHGV ETGIIKRLPH GAYIELHQPL GPVDEHGHPI
     PLQYQGAPLP KRMNKLGSAG SPGSGSFLFA DSAAEDAALR EAGHAAEQRA LAALREHQDS
     IMGSPDGEH
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024